Amplia Therapeutics Ltd.ASX: ATX

AMP886 Activity in Acute Myeloid Leukemia

Oct 3, 2022 at 1:41 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment